GABA analogs to prevent and treat gastrointestinal damage
US6127418A · kind A · utility
32Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Apr 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a method for preventing visceral and gastrointestinal damage such as gastric ulcers by administering a gamma-aminobutyric acid (GABA) analog and for treating gastrointestinal diseases such as inflammatory bowel disorders (IBD), functional bowel disorders (FBD) including dyspepsia and other visceral pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.